UBS Group’s Traws Pharma TRAW Stock Holding History
Bought
Maintained
Sold
Other funds holding TRAW
LCM
UBS Group's TRAW Position: Q3 2026 in Review
UBS Group increased its Traws Pharma (TRAW) stake by 468% in Q3 2026, buying an estimated $9.29K and bringing the position to 19,616 shares worth $11.7K. The position accounts for ﹤0.01% of the portfolio, ranked #8958.
UBS Group first reported a position in TRAW in Q4 2015 and has held it in 36 quarters since. The position peaked at $71K in Q2 2020. 34 funds tracked by Wall St. Rank hold TRAW as of Q3 2026.
- UBS Group held 19,616 shares of Traws Pharma worth $11.7K as of Q3 2026.
- UBS Group bought 16,165 Traws Pharma shares in Q3 2026, an estimated $9.29K.
- Traws Pharma made up ﹤0.01% of UBS Group's portfolio in Q3 2026, its #8958 holding.
- UBS Group first reported a position in Traws Pharma in Q4 2015 and has held it in 36 quarters since.
- UBS Group's Traws Pharma position peaked at $71K in Q2 2020.
- 34 funds tracked by Wall St. Rank held Traws Pharma as of Q3 2026.
Based on UBS Group's 13F filing for Q3 2026, filed 10 Nov 2026.